RxDoctor Payments Data

Anna Schell

Family · Washington, MONPI 1518341734

Payments from drug & device makers

$1,592in general payments, 2019–2025

Across 84 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$186
  • AstraZeneca$150
  • AbbVie$141
  • Radius Health, Inc.$140
  • Novo Nordisk$132
  • Pfizer$114
  • plus $730 from 18 others

What the payments were for

  • Food & beverage$1,592100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,592 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$18,214
Medicare patients
71
Services billed
406

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$39,706
JardianceEmpagliflozin32$33,966
TrulicityDulaglutide19$26,956
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$21,319
EliquisApixaban19$21,244
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/717$9,620
Tresiba Flextouch U-100Insulin Degludec13$9,054
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$3,454
Bupropion XlBupropion Hcl45$2,316
Mirtazapine31$1,801
Albuterol Sulfate HfaAlbuterol Sulfate56$1,451
Levothyroxine Sodium103$1,234
Losartan Potassium68$937
Rosuvastatin Calcium75$877
Atorvastatin Calcium97$765

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$132$39,70632 claims
Boehringer IngelheimJardiance$14$33,96632 claims
Lilly USA, LLCTrulicity$78$26,95619 claims
GSKTrelegy Ellipta$50$21,31933 claims
PfizerEliquis$114$21,24419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.

Other family in Washington

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →